Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells.

Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells.
复制标题

DOI:
10.1038/sj.bjc.6603354
复制
发表时间:
2006-11-06
影响因子:
8.8
通讯作者:
Yee, D.
Yee, D.
中科院分区:
医学1区
文献类型:
--
作者:
Byron, S. A.;Horwitz, K. B.;Richer, J. K.;Lange, C. A.;Zhang, X.;Yee, D.

文献摘要

参考文献

被引文献

相似文献

I型胰岛素样生长因子受体(IGF-IR)的激活调节恶性表型的几个方面,包括癌细胞的增殖和转移。IGF-IR下游接头蛋白的磷酸化可能会将IGF的作用偶联到特定的癌症表型。在这项研究中,我们试图确定胰岛素受体底物-1和-2(IRS-1和-2)是否在乳腺癌细胞中介导不同的生物学效应。T47D-YA乳腺癌细胞表达胰岛素受体底物-1和IRS-2,表达IRS-1和IRS-2,但保留功能性IGF-IR。在IRS-1和IRS-2表达缺失的情况下,IGF-IR的激活不能刺激T47D-YA细胞的增殖或运动。IRS-1的表达促进了IGF-I刺激的细胞增殖,但不影响细胞的运动能力。相反,IRS-2的表达增强了IGF-I刺激的运动能力,但不能刺激增殖。胰岛素样生长因子-IR的抑制剂α-IR-3不能影响胰岛素样生长因子刺激的表型,除非表达胰岛素样生长因子-1或-2。因此,IGF-IR单独不能调节重要的乳腺癌细胞表型。在这些细胞中,IRS蛋白是IGF-IR刺激行为的不同方面所必需的,并参与其调节。由于多个靶向IGF-IR的药物目前处于早期临床试验中,IRS的表达应被视为IGF-IR反应性的潜在生物标志物。
Activation of the type I insulin-like growth factor receptor (IGF-IR) regulates several aspects of the malignant phenotype, including cancer cell proliferation and metastasis. Phosphorylation of adaptor proteins downstream of IGF-IR may couple IGF action to specific cancer phenotypes. In this study, we sought to determine if insulin receptor substrate-1 and -2 (IRS-1 and -2) mediate distinct biological effects in breast cancer cells. Insulin receptor substrate-1 and IRS-2 were expressed in T47D-YA breast cancer cells, which lack IRS-1 and -2 expression, yet retain functional IGF-IR. In the absence of IRS-1 and -2 expression, IGF-IR activation was unable to stimulate proliferation or motility in T47D-YA cells. Expression of IRS-1 resulted in IGF-I-stimulated proliferation, but did not affect motility. In contrast, expression of IRS-2 enhanced IGF-I-stimulated motility, but did not stimulate proliferation. The αIR-3, an inhibitor of the IGF-IR, was unable to affect these IGF-stimulated phenotypes unless IRS-1 or -2 was expressed. Thus, IGF-IR alone is unable to regulate important breast cancer cell phenotypes. In these cells, IRS proteins are required for and mediate distinct aspects of IGF-IR-stimulated behaviour. As multiple agents targeting the IGF-IR are currently in early clinical trials, IRS expression should be considered as a potential biomarker for IGF-IR responsiveness.
DOI: 10.1002/j.1460-2075.1990.tb08280.x
发表时间: 1990-05-01
期刊: EMBO JOURNAL
影响因子: 11.4
作者:
KASTNER, P;KRUST, A;CHAMBON, P
通讯作者: CHAMBON, P
DOI: 10.1002/jcp.1041570204
发表时间: 1993-11-01
影响因子: 5.6
作者:
FIGUEROA, JA;SHARMA, J;YEE, D
通讯作者: YEE, D
DOI: 10.1038/sj.onc.1204920
发表时间: 2001-11-01
期刊: ONCOGENE
影响因子: 8
作者:
Jackson, JG;Zhang, XH;Yee, D
通讯作者: Yee, D
DOI: 10.1007/bf01833338
发表时间: 1992-01-01
影响因子: 3.8
作者:
ARTEAGA, CL
通讯作者: ARTEAGA, CL
DOI: 10.1054/ghir.1999.0113
发表时间: 1999-10-01
影响因子: 1.4
作者:
Jackson, JG;Yee, D
通讯作者: Yee, D